Epilepsy may result from abnormal function of ion channels, such as those caused by genetic mutations. Recently, pathological alterations of the expression or localization of normal channels have been implicated in epilepsy generation, and termed 'acquired channelopathies'. Altered expression levels of the HCN channels -that conduct the hyperpolarization-activated current, I h -have been demonstrated in hippocampus of patients with severe temporal lobe epilepsy as well as in animal models of temporal lobe and absence epilepsies. Here we probe the mechanisms for the altered expression of HCN channels which is provoked by seizures. In organotypic hippocampal slice cultures, seizure-like events selectively reduced HCN type 1 channel expression and increased HCN2 mRNA levels, as occurs in vivo. The mechanisms for HCN1 reduction involved Ca 2+ -permeable AMPA receptor-mediated Ca 2+ influx, and subsequent activation of Ca 2+ /calmodulin-dependent protein kinase II. In contrast, upregulation of HCN2 expression was independent of these processes. The data demonstrate an orchestrated program for seizure-evoked transcriptional channelopathy involving the HCN channels that may contribute to certain epilepsies.
Introduction
Mutations in over 70 ion channel genes lead to human diseases including cardiac arrhythmia, ataxia, chronic pain, neuropathy and epilepsy (Noebels, 2003; Jentsch et al., 2004; Waxman and Hains, 2006) . This fact has given rise to the concept of 'channelopathy' as a basis for neuronal dysfunction that culminates in disease (Waxman, 2001; Noebels, 2003) . More recently, it has been increasingly recognized that abnormal expression levels of otherwise intact ion channels (Su et al., 2002; Ellerkmann et al., 2003; Peters et al., 2005) , or channel expression in the 'wrong' location or cells, might also promote neurological disorders. These findings have been termed "transcriptional (or acquired) channelopathies" (Waxman, 2001) . Focusing on epilepsy, long-lasting changes in the expression levels of chloride channels (GABA A receptors; Brooks-Kayal et al., 1998), sodium channels (Ellerkmann et al., 2003) , calcium channels (Su et al., 2002) and the hyperpolarization-activated cationic (HCN) channels (Chen et al., 2001; Brewster et al., 2002; Bender et al., 2003) have been found to promote pathological brain activity. Therefore, better understanding of the mechanisms that lead to abnormal expression patterns of these ion channels is important, because it should provide molecular targets for intervention in the pathological disease process.
The HCN channels conduct the hyperpolarization-activated cationic current, I h , an important regulator of resting membrane potential of neurons (Maccaferri and McBain, 1996; Lupica et al., 2001) and their responses to network activity (Maccaferri and McBain, 1996; Magee, 1999; Poolos et al., 2002) . The properties of I h are governed, at least in part, by the subunit composition of HCN channels, that are encoded by a family of genes (Ludwig et al., 1998; Santoro et al., 2000; Santoro and Baram, 2003) . In human and rodent hippocampus and cortex, two isoforms (HCN1 and 2) predominate (Poolos et al., 2002; Robinson and Siegelbaum, 2003; Brewster et al., 2007) . HCN1 channels conduct a relatively fast-kinetics current with modest cAMP gating, consistent with currents recorded in hippocampal pyramidal cells and CA1 interneurons where HCN1 expression is high (Magee, 1999; Lupica et al., 2001; Poolos et al., 2002; Vasilyev and Barish, 2002; Surges et al., 2006; Brewster et al., 2002 Brewster et al., , 2007 . In contrast, the HCN2 gene encodes a channel with slower kinetics and robust cAMP-evoked shifts in voltage dependence (Santoro et al., 2000) . Changes in HCN channel expression have been found in surgical specimens from patients with temporal lobe epilepsy and severe hippocampal sclerosis (Bender
